Hydroxychloroquine in a COVID-19 patient on chronic Pregabalin therapy- Is it safe?
作者信息
Chilkoti Geetanjali Tolia, Malik Anish, Mohta Medha, Saxena Ashok Kumar
机构信息
Department of Anesthesiology and Critical Care, University College of Medical Sciences and Guru Teg Bahadur hospital, Shahdara, Delhi, India.
出版信息
J Anaesthesiol Clin Pharmacol. 2022 Jul;38(Suppl 1):S127-S128. doi: 10.4103/joacp.JOACP_587_20. Epub 2022 Jan 7.
Abstract
摘要
相似文献
1
Hydroxychloroquine in a COVID-19 patient on chronic Pregabalin therapy- Is it safe?正在接受普瑞巴林长期治疗的新冠肺炎患者使用羟氯喹是否安全？
J Anaesthesiol Clin Pharmacol. 2022 Jul;38(Suppl 1):S127-S128. doi: 10.4103/joacp.JOACP_587_20. Epub 2022 Jan 7.
2
Protocol-based cardiotoxicity monitoring in hydroxychloroquine medicated COVID-19 pediatric patients.基于方案的羟氯喹治疗的COVID-19儿科患者心脏毒性监测
Rev Port Cardiol. 2022 Feb;41(2):155-163. doi: 10.1016/j.repc.2021.01.018. Epub 2021 Sep 22.
3
Incidence of COVID-19 in patients under chronic treatment with hydroxychloroquine.羟氯喹慢性治疗患者 COVID-19 的发生率。
Med Clin (Barc). 2021 Feb 26;156(4):166-171. doi: 10.1016/j.medcli.2020.10.006. Epub 2020 Nov 6.
4
Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.抗病毒联合治疗在新冠病毒感染有症状患者中的安全性和有效性 - 一项随机对照试验（SEV-COVID 试验）：一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 20;21(1):866. doi: 10.1186/s13063-020-04774-5.
5
A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19.羟氯喹预防 COVID-19 的集群随机试验。
N Engl J Med. 2021 Feb 4;384(5):417-427. doi: 10.1056/NEJMoa2021801. Epub 2020 Nov 24.
6
COVID-19 Pneumonia in Patients on Chronic Hydroxychloroquine Therapy: Three Cases of COVID-19 Pneumonia.接受慢性羟氯喹治疗的患者中的 COVID-19 肺炎：三例 COVID-19 肺炎病例
Case Rep Infect Dis. 2020 Oct 22;2020:8822753. doi: 10.1155/2020/8822753. eCollection 2020.
7
Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine.新冠疫情下药物的重新利用：氯喹和羟氯喹的药代动力学和药物基因组学
Pharmgenomics Pers Med. 2020 Oct 23;13:531-542. doi: 10.2147/PGPM.S275964. eCollection 2020.
8
COVID-19 in Patient with Sarcoidosis Receiving Long-Term Hydroxychloroquine Treatment, France, 2020.2020 年法国长期接受羟氯喹治疗的类肉瘤病患者中的 COVID-19 病例。
Emerg Infect Dis. 2020 Oct;26(10):2513-2515. doi: 10.3201/eid2610.201816. Epub 2020 Jul 1.
9
Incidence of COVID-19 in patients under chronic treatment with hydroxychloroquine.接受羟氯喹长期治疗的患者中新冠病毒病的发病率。
Med Clin (Engl Ed). 2021 Feb 26;156(4):166-171. doi: 10.1016/j.medcle.2020.10.012. Epub 2021 Jan 23.
10
Proactive prophylaxis with azithromycin and hydroxychloroquine in hospitalized patients with COVID-19 (ProPAC-COVID): a statistical analysis plan.COVID-19 住院患者中阿奇霉素和羟氯喹的主动预防（ProPAC-COVID）：统计分析计划。
Trials. 2020 Oct 20;21(1):867. doi: 10.1186/s13063-020-04795-0.
本文引用的文献
1
Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection.氯喹、羟氯喹和阿奇霉素对 SARS-CoV-2 感染患者校正 QT 间期的影响。
Circ Arrhythm Electrophysiol. 2020 Jun;13(6):e008662. doi: 10.1161/CIRCEP.120.008662. Epub 2020 Apr 29.
2
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.羟氯喹和阿奇霉素治疗 COVID-19：一项开放标签非随机临床试验的结果。
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
3
Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database.加巴喷丁和普瑞巴林与老年人心房颤动风险：电子处方数据库中的一项基于人群的队列研究。
Drug Saf. 2018 Dec;41(12):1325-1331. doi: 10.1007/s40264-018-0695-6.
4
First Description of QTc Prolongation Associated With Clonazepam Overdose in a Pediatric Patient.首例小儿患者氯硝西泮过量导致QTc延长的病例描述
Am J Ther. 2018 Sep/Oct;25(5):e558-e561. doi: 10.1097/MJT.0000000000000639.
5
Effects of therapeutic doses of Pregabalin on QTc interval in conscious rabbits.治疗剂量的普瑞巴林对清醒家兔QTc间期的影响。
Eur Rev Med Pharmacol Sci. 2008 Jul-Aug;12(4):223-8.
Zotero 插件